CN111443200B - 一种猪圆环病毒2型病毒样颗粒的夹心elisa定量检测法 - Google Patents
一种猪圆环病毒2型病毒样颗粒的夹心elisa定量检测法 Download PDFInfo
- Publication number
- CN111443200B CN111443200B CN202010253460.0A CN202010253460A CN111443200B CN 111443200 B CN111443200 B CN 111443200B CN 202010253460 A CN202010253460 A CN 202010253460A CN 111443200 B CN111443200 B CN 111443200B
- Authority
- CN
- China
- Prior art keywords
- liquid
- pcv2
- vlps
- plate
- pbst
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241001673669 Porcine circovirus 2 Species 0.000 title claims abstract description 103
- 238000003118 sandwich ELISA Methods 0.000 title claims abstract description 29
- 239000002245 particle Substances 0.000 title claims abstract description 24
- 238000001514 detection method Methods 0.000 title claims abstract description 15
- 229920002971 Heparan sulfate Polymers 0.000 claims abstract description 47
- 238000006243 chemical reaction Methods 0.000 claims abstract description 35
- 238000000034 method Methods 0.000 claims abstract description 35
- 238000002965 ELISA Methods 0.000 claims abstract description 17
- 238000011002 quantification Methods 0.000 claims abstract description 12
- 238000005457 optimization Methods 0.000 claims abstract description 6
- 239000000126 substance Substances 0.000 claims abstract description 4
- 239000007788 liquid Substances 0.000 claims description 76
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 claims description 42
- 238000005406 washing Methods 0.000 claims description 24
- 238000001035 drying Methods 0.000 claims description 19
- 230000000903 blocking effect Effects 0.000 claims description 14
- 239000013642 negative control Substances 0.000 claims description 11
- 102000004190 Enzymes Human genes 0.000 claims description 10
- 108090000790 Enzymes Proteins 0.000 claims description 10
- 238000007865 diluting Methods 0.000 claims description 10
- 241000283707 Capra Species 0.000 claims description 9
- 238000010009 beating Methods 0.000 claims description 9
- 241000202347 Porcine circovirus Species 0.000 claims description 3
- 238000012286 ELISA Assay Methods 0.000 claims 1
- 239000011248 coating agent Substances 0.000 abstract description 21
- 238000000576 coating method Methods 0.000 abstract description 21
- 238000011156 evaluation Methods 0.000 abstract description 5
- 230000035945 sensitivity Effects 0.000 abstract description 2
- 108090000623 proteins and genes Proteins 0.000 description 20
- 102000004169 proteins and genes Human genes 0.000 description 20
- 235000018102 proteins Nutrition 0.000 description 16
- 239000000243 solution Substances 0.000 description 15
- 239000006228 supernatant Substances 0.000 description 15
- 239000000523 sample Substances 0.000 description 14
- 241000283973 Oryctolagus cuniculus Species 0.000 description 12
- 230000001580 bacterial effect Effects 0.000 description 10
- 101100382437 Porcine circovirus 2 Cap gene Proteins 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 9
- 230000014509 gene expression Effects 0.000 description 8
- 239000008188 pellet Substances 0.000 description 8
- 239000000872 buffer Substances 0.000 description 7
- 239000013612 plasmid Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 230000035484 reaction time Effects 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 6
- 230000009089 cytolysis Effects 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 108090001074 Nucleocapsid Proteins Proteins 0.000 description 5
- 241000282887 Suidae Species 0.000 description 5
- 230000003053 immunization Effects 0.000 description 5
- 238000002649 immunization Methods 0.000 description 5
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 5
- 238000004445 quantitative analysis Methods 0.000 description 5
- 238000009210 therapy by ultrasound Methods 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- 239000000427 antigen Substances 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 4
- 239000012723 sample buffer Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 238000001042 affinity chromatography Methods 0.000 description 3
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000002808 molecular sieve Substances 0.000 description 3
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 3
- 238000004627 transmission electron microscopy Methods 0.000 description 3
- 229960005486 vaccine Drugs 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241001529936 Murinae Species 0.000 description 2
- 241000283977 Oryctolagus Species 0.000 description 2
- 241000282898 Sus scrofa Species 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 238000001493 electron microscopy Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000009465 prokaryotic expression Effects 0.000 description 2
- 238000001742 protein purification Methods 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 208000031295 Animal disease Diseases 0.000 description 1
- 101150044789 Cap gene Proteins 0.000 description 1
- 241001533399 Circoviridae Species 0.000 description 1
- 108020004638 Circular DNA Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 101710085938 Matrix protein Proteins 0.000 description 1
- 101710127721 Membrane protein Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010029164 Nephrotic syndrome Diseases 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 208000005342 Porcine Reproductive and Respiratory Syndrome Diseases 0.000 description 1
- 241000702619 Porcine parvovirus Species 0.000 description 1
- 239000012722 SDS sample buffer Substances 0.000 description 1
- 241000194021 Streptococcus suis Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000005323 carbonate salts Chemical class 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- DIUIQJFZKRAGBZ-UHFFFAOYSA-N chetoseminudin A Natural products O=C1C(SSS2)(CO)N(C)C(=O)C32CC2(N4C5=CC=CC=C5C(CC56C(N(C)C(CO)(SS5)C(=O)N6C)=O)=C4)C4=CC=CC=C4NC2N31 DIUIQJFZKRAGBZ-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- AVFBYUADVDVJQL-UHFFFAOYSA-N phosphoric acid;trioxotungsten;hydrate Chemical compound O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.OP(O)(O)=O AVFBYUADVDVJQL-UHFFFAOYSA-N 0.000 description 1
- 208000028489 postweaning multisystemic wasting syndrome Diseases 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 238000000197 pyrolysis Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000007921 solubility assay Methods 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 208000002254 stillbirth Diseases 0.000 description 1
- 231100000537 stillbirth Toxicity 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 229940031626 subunit vaccine Drugs 0.000 description 1
- 239000013595 supernatant sample Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 238000005199 ultracentrifugation Methods 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
包被类型 | HS | BSA | PBS |
阳性OD值 | 1.189 | 0.264 | 0.212 |
阴性OD值 | 0.068 | 0.068 | 0.062 |
P/N值 | 17.485 | 3.882 | 3.459 |
包被液 | PBS | 碳酸盐 |
阳性OD值 | 1.834 | 1.721 |
阴性OD值 | 0.077 | 0.076 |
P/N值 | 23.818 | 22.644 |
反应时间 | 30 min | 45 min | 60 min |
阳性OD值 | 0.416 | 0.709 | 1.324 |
阴性OD值 | 0.058 | 0.059 | 0.058 |
P/N值 | 7.172 | 12.017 | 22.828 |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010253460.0A CN111443200B (zh) | 2020-04-02 | 2020-04-02 | 一种猪圆环病毒2型病毒样颗粒的夹心elisa定量检测法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010253460.0A CN111443200B (zh) | 2020-04-02 | 2020-04-02 | 一种猪圆环病毒2型病毒样颗粒的夹心elisa定量检测法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111443200A CN111443200A (zh) | 2020-07-24 |
CN111443200B true CN111443200B (zh) | 2023-06-27 |
Family
ID=71651117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010253460.0A Active CN111443200B (zh) | 2020-04-02 | 2020-04-02 | 一种猪圆环病毒2型病毒样颗粒的夹心elisa定量检测法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111443200B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102488895A (zh) * | 2011-12-30 | 2012-06-13 | 重庆大学 | 一种猪圆环病毒、猪细小病毒、猪繁殖与呼吸综合症病毒三联病毒样颗粒疫苗及其制备方法 |
CN106191320A (zh) * | 2016-07-29 | 2016-12-07 | 中山大学 | Hpse基因在筛选抗蓝耳病猪中的应用 |
CN109265521A (zh) * | 2018-09-13 | 2019-01-25 | 湖南农业大学 | PCV2 Loop EF区的突变体、引物及其制备方法和应用 |
CN110887963A (zh) * | 2019-11-25 | 2020-03-17 | 江苏南农高科技股份有限公司 | 一种pcv2病毒样颗粒夹心定量elisa检测法及其应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CL2015003257A1 (es) * | 2015-11-05 | 2016-06-24 | Univ Chile | Vacuna de administración vía mucosas, para el control de las enfermedades generadas por agentes infecciosos que utilizan el heparán sulfato (hs) como receptor celular |
CN109799351A (zh) * | 2018-09-19 | 2019-05-24 | 天津瑞普生物技术股份有限公司 | 猪圆环病毒2型双抗体夹心elisa试剂盒及其应用 |
-
2020
- 2020-04-02 CN CN202010253460.0A patent/CN111443200B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102488895A (zh) * | 2011-12-30 | 2012-06-13 | 重庆大学 | 一种猪圆环病毒、猪细小病毒、猪繁殖与呼吸综合症病毒三联病毒样颗粒疫苗及其制备方法 |
CN106191320A (zh) * | 2016-07-29 | 2016-12-07 | 中山大学 | Hpse基因在筛选抗蓝耳病猪中的应用 |
CN109265521A (zh) * | 2018-09-13 | 2019-01-25 | 湖南农业大学 | PCV2 Loop EF区的突变体、引物及其制备方法和应用 |
CN110887963A (zh) * | 2019-11-25 | 2020-03-17 | 江苏南农高科技股份有限公司 | 一种pcv2病毒样颗粒夹心定量elisa检测法及其应用 |
Non-Patent Citations (3)
Title |
---|
Porcine circovirus 2 uses a multitude of weak binding sites to interact with heparan sulfate, and the interactions do not follow the symmetry of the capsid;Sonali Dhindwal等;《Journal of Virology》;全文 * |
猪圆环病毒2型抗体胶体金免疫层析检测方法的建立;张禹等;《中国预防兽医学报》;第41卷(第7期);全文 * |
猪圆环病毒2型病毒样颗粒的研究及应用;余婉婷;湛洋;雷昕诺;张颜;谢小红;王乃东;邓治邦;王爱兵;杨毅;;中国畜牧兽医文摘(第05期);全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN111443200A (zh) | 2020-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110964102B (zh) | 能同时与犬、猫、水貂细小病毒结合的单克隆抗体、其可变区序列、杂交瘤细胞株及应用 | |
CN110105436B (zh) | 猪圆环病毒3型抗体的elisa检测试剂盒及其制备方法与应用 | |
CN105606826B (zh) | 一种酶联免疫检测禽鹦鹉热衣原体的试剂盒 | |
CN108226494B (zh) | 猪繁殖与呼吸综合征病毒elisa抗体检测试剂盒 | |
CN113684189A (zh) | 一株鸡新型圆圈病毒3型毒株及基于该病毒的检测体系 | |
CN107664697B (zh) | 表达载体及其制备方法、pedv-s1蛋白及包含该蛋白的间接elisa检测试剂盒 | |
CN113637069A (zh) | 猪圆环病毒4型Cap蛋白单克隆抗体及其制备方法和应用 | |
CN110887963B (zh) | 一种pcv2病毒样颗粒夹心定量elisa检测法及其应用 | |
CN111443200B (zh) | 一种猪圆环病毒2型病毒样颗粒的夹心elisa定量检测法 | |
CN112505333B (zh) | 一种旋毛虫竞争elisa抗体检测试剂盒及其检测方法 | |
CN108776225A (zh) | 猪细小病毒VLPs抗体检测试剂盒及其制备方法、应用 | |
CN110156878B (zh) | 猪伪狂犬病毒gE-gI蛋白及其表达质粒、制备方法和应用 | |
CN116925218A (zh) | 小热休克蛋白hspb1的抗体、抗体组合物、杂交瘤细胞株及其应用 | |
CN108872580B (zh) | 一种检测新型鹅细小病毒的胶体金试纸条及其制备方法 | |
CN112521495B (zh) | 一种小反刍兽疫病毒ppr-n蛋白单克隆抗体的制备及其应用 | |
CN110018314B (zh) | 一种禽流感蛋白抗体检测试剂盒 | |
CN110607282B (zh) | 牛细小病毒单克隆抗体及其在检测牛细小病毒感染中的应用 | |
CN116068192A (zh) | 一种检测非洲猪瘟病毒抗体的ELISA检测试剂盒以及protein L的应用 | |
CN110196325B (zh) | 塞内卡病毒病诊断试剂盒及试纸 | |
CN109932504B (zh) | 用于检测鳜鱼弹状病毒的试剂盒 | |
CN110229218B (zh) | 检测塞内卡病毒抗体的试剂及其所用多肽 | |
CN109265522B (zh) | 用于检测犬瘟热病毒血凝蛋白h抗体的致敏聚苯乙烯纳米微球及其制备方法和应用 | |
CN110702925A (zh) | 同时检测csfv、ppv、jev、prrsv抗体的荧光标记蛋白芯片制备和检测方法 | |
CN114249819A (zh) | 猫泛白细胞减少症病毒抗体、含有猫泛白细胞减少症病毒抗体的试剂盒及应用 | |
CN108896767A (zh) | 一种基于xMAP技术的PCV2抗体检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240122 Address after: 410000 No. 1 Nongda Road, Furong District, Changsha City, Hunan Province Patentee after: Wang Naidong Country or region after: China Patentee after: Hunan Yangming Biotechnology Co.,Ltd. Address before: 425100 Intersection of Lingling South Road and Chengnan Avenue, Changfeng Industrial Park, Yongzhou City, Hunan Province Patentee before: Hunan Yangming Yongkang Biotechnology Co.,Ltd. Country or region before: China Patentee before: Hunan Yangming Biotechnology Co.,Ltd. |
|
TR01 | Transfer of patent right |